Invention Grant
- Patent Title: Imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase
-
Application No.: US16500885Application Date: 2018-04-05
-
Publication No.: US11325905B2Publication Date: 2022-05-10
- Inventor: Dennis Hall , Michael Weinfeld , Sylvain Bernard , Tristan Verdelet , Timothy Morgan , Vikie Lamontagne , Zahra Shire , Afsaneh Lavasanifar
- Applicant: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
- Applicant Address: CA Edmonton
- Assignee: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
- Current Assignee: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
- Current Assignee Address: CA Edmonton
- Agency: Clark & Elbing LLP
- International Application: PCT/CA2018/050422 WO 20180405
- International Announcement: WO2018/184113 WO 20181011
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K47/62 ; A61P35/00 ; A61K9/107 ; A61K47/34 ; A61K31/4745
Abstract:
There is described herein imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase.
Public/Granted literature
- US20200148675A1 IMIDOPIPERIDINE COMPOUNDS AS INHIBITORS OF HUMAN POLYNUCLEOTIDE KINASE PHOSPHATASE Public/Granted day:2020-05-14
Information query
